The Lancet Haematology

The Lancet Haematology is an exclusively online journal dedicated to publishing original research that advocates change in, or illuminates, haematological clinical practice, including, but not limited to, the subjects of: haematology-oncology, red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, and transfusion medicine.

Publisher
Elsevier
History
2014
Website
http://thelancet.com/journals/lanhae/issue/current

Some content from Wikipedia, licensed under CC BY-SA

Oncology & Cancer

The natural artistry of disease: A wintry landscape in the eye

Leukemias and lymphomas are life-threatening malignancies affecting white blood cells and the immune system; fortunately, radiotherapy and chemotherapy, combined with stem cell therapy, can improve survival significantly. ...

Diseases, Conditions, Syndromes

Test to detect blood vessel injury, predict survival in COVID-19

Researchers at Yale have found that injury to endothelial cells—the cells lining blood vessels—may be a key driver of COVID-19 severity and death. The findings, published in the June 30 edition of The Lancet Haematology, ...

Medical research

Controverse viewpoints: Controlled drug trials in children

In the Pro and Con debate in Lancet Haematology, Christoph Male from the Department of Paediatrics and Adolescent Medicine, Medical University of Vienna, argues for controlled drug trials in children. The example discussed ...

Diseases, Conditions, Syndromes

Favorable outcomes seen in long term for ALLR3 trial

(HealthDay)—For children with B-cell precursor acute lymphoblastic leukemia with late bone marrow relapse, risk stratification by minimal residual disease seems to be an effective strategy for treatment, according to a ...

Oncology & Cancer

Blood diseases cured with bone marrow transplant

Doubling the low amount of total body radiation delivered to patients undergoing bone marrow transplants with donor cells that are only "half-matched" increased the rate of engraftment from only about 50 percent to nearly ...

Oncology & Cancer

Financial disclosure lacking in publication of clinical trials

A substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not disclosed, new research shows. The publications focused on clinical trials ...

page 1 from 2